Vericel Corporation (VCEL)
NASDAQ: VCEL · Real-Time Price · USD
57.97
+0.71 (1.24%)
Nov 21, 2024, 11:05 AM EST - Market open
Vericel Employees
Vericel had 314 employees as of December 31, 2023. The number of employees increased by 9 or 2.95% compared to the previous year.
Employees
314
Change (1Y)
9
Growth (1Y)
2.95%
Revenue / Employee
$722,433
Profits / Employee
$11,299
Market Cap
2.87B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Surgery Partners | 13,500 |
LifeStance Health Group | 9,325 |
Concentra Group Holdings Parent | 9,020 |
Warby Parker | 3,473 |
LivaNova | 2,900 |
Inari Medical | 1,300 |
Amicus Therapeutics | 517 |
SpringWorks Therapeutics | 305 |
VCEL News
- 13 days ago - Vericel Corporation (VCEL) Q3 2024 Earnings Conference Call Transcript - Seeking Alpha
- 14 days ago - Vericel Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 4 weeks ago - Vericel to Report Third-Quarter 2024 Financial Results on November 7, 2024 - GlobeNewsWire
- 3 months ago - Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024 - GlobeNewsWire
- 3 months ago - Vericel Announces FDA Approval and Commercial Availability of MACI Arthro - GlobeNewsWire
- 3 months ago - Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns - GlobeNewsWire
- 3 months ago - Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024 - GlobeNewsWire
- 3 months ago - Vericel Corporation (VCEL) Q2 2024 Earnings Call Transcript - Seeking Alpha